The increase of the absolute number of CD3+CD4+ lymphocytes in patients with COPD compared with the control group, patients with asthma and ACOS (p1-2 = 0.000001, p2-3 = 0.000010, and p2-4 = 0.0000132, resp). This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.